St George's Healthcare NHS Trust
16
2
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.3%
1 terminated/withdrawn out of 16 trials
85.7%
-0.8% vs industry average
13%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Role: collaborator
Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
Role: collaborator
Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina
Role: collaborator
Telaprevir in Genotype 3 HCV
Role: collaborator
Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?
Role: collaborator
A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)
Role: collaborator
A Naturalistic Controlled Trial of Individual Placement and Control in Bodø
Role: collaborator
Respiratory Syncytial Virus (RSV) and Vaccination in Pregnancy
Role: collaborator
Protective Role of Oxcarbazepine in Multiple Sclerosis
Role: collaborator
Response to Varying the Rate of Administration of a Fluid Challenge
Role: lead
Nitrites in Acute Myocardial Infarction
Role: collaborator
Assessment of a Skin Barrier
Role: collaborator
Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum
Role: lead
Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries
Role: lead
Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.
Role: lead
Total Versus Subtotal Hysterectomy:a Randomised, Prospective Multicentre Study of the Effect on Urinary, Sexual and Bowel Function
Role: lead
All 16 trials loaded